Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
ALX Oncology Holdings Inc.:
We consent to the use of our report incorporated by reference herein.
/s/ KPMG LLP
San Francisco, California
March 18, 2021
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
ALX Oncology Holdings Inc.:
We consent to the use of our report incorporated by reference herein.
/s/ KPMG LLP
San Francisco, California
March 18, 2021
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.